Rein Therapeutics, Inc. Temporary Equity, Liquidation Preference
Rein Therapeutics, Inc. (RNTX) had Temporary Equity, Liquidation Preference of $130.71 million as of 2017-06-30, per its 10-Q filed 2017-08-10.
Discontinued › Balance Sheet › Equity › Temporary Equity
us-gaap:TemporaryEquityLiquidationPreference · last filed 2018-04-02
- 2017-06-30: Temporary Equity, Liquidation Preference $130.71M.
- 2016-12-31: Temporary Equity, Liquidation Preference $130.05M.
| Period end | Temporary Equity, Liquidation Preference |
|---|---|
| 2017-06-30 | $130.71M 10-Q · filed 2017-08-10 |
| 2016-12-31 | $130.05M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |